Drug class
Angiotensin-converting enzyme (ACE) inhibitor; antihypertensive and cardiovascular agent
Mechanism of action
Prodrug hydrolysed to cilazaprilat, which inhibits ACE and reduces conversion of angiotensin I to angiotensin II, lowering vasoconstriction and aldosterone secretion.
General use cases
- Treatment of hypertension in adults in countries where cilazapril is authorised
- Treatment of heart failure in selected patients under country-specific product information; dosing and monitoring are required
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
